BROOKLYN CURLEY: Open Payments
NPI 1942994546 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,890 in 112 payments from 21 companies in 2025. Trend: 2023 $404 · 2024 $2,797 · 2025 $2,890
Food & beverage: $2,786Education: $104
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $556 |
| Regeneron Healthcare Solutions, Inc. | 12 | $406 |
| Janssen Biotech, Inc. | 7 | $254 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $253 |
| ABBVIE INC. | 12 | $238 |
| Galderma Laboratories, L.P. | 13 | $162 |
| GENZYME CORPORATION | 4 | $144 |
| Janssen Scientific Affairs, LLC | 1 | $134 |
| Botanix SB Inc | 7 | $117 |
| LEO Pharma Inc. | 6 | $115 |
Products named: Bimzelx, DUPIXENT, TREMFYA, ILUMYA, SKYRIZI, NEMLUVIO, SOFDRA, ADBRY.
Industry payments across FL — which companies pay providers there.
